BAXTER TRAVENOL IS GOING GENERIC ROUTE TO HOSPITAL DRUG BUSINESS: COMPANY BUYS ASCOT AND ANNOUNCES INTENT TO SELL AMERICAN CRITICAL CARE & FLINT